“Alternative Therapies: Anti-TNF (Infliximab, And Adalimumab) Agents And Radiological Response For Refractory Sarcoidosis”. 2025. The Review of Diabetic Studies, September, 768-84. https://doi.org/10.70082/bzt09243.